TGFB1 and COVID-19: Given the TGF-β-induced chronic immune response observed in severe COVID-19 patients37 and prompted by the functional associations of miR-144 predicted targets with TGF-beta signaling pathways, we also measured plasma TGF-β levels that was not included in the cytokine panel used for the seroproteomic analysis.